Evidence check: Homocystein in the context of Blutzucker

Homocysteine is a sulfur-containing amino acid derivative; elevated blood levels (hyperhomocysteinemia) are associated in epidemiological studies with increased risk of cardiovascular disease, insulin resistance, and type 2 diabetes. The link to blood sugar is plausible because homocysteine can impair endothelial function and promote oxidative stress, which may reduce insulin sensitivity. However, the evidence is largely observational; randomized controlled trials show that lowering homocysteine with folic acid, vitamin B12, and B6 is possible but does not consistently improve glycemic control. Thus, its clinical relevance as an independent risk factor remains debated. For DNA tests on homocysteine-related genes (e.g., MTHFR), caution is warranted: the common C677T variant reduces enzyme activity, but its effect on homocysteine levels is moderate and strongly influenced by nutrient intake. A genetic test alone cannot reliably predict blood sugar risk. Instead, established markers like HbA1c, fasting glucose, and lifestyle factors should be prioritized. The evidence for a direct causal role of homocysteine in blood sugar metabolism is considered moderate.